Large-scale testing (Phase 3)Looking for participantsNCT07282600
What this trial is testing
Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Who this might be right for
OverweightObesity
Eli Lilly and Company 1,035